Join the #FierceMadness!
Pick your favorite drug names in this year's tournament challenge. Read more and vote here!
Jerrod Nichols Smith, one of three people indicted in 2013 for a drug wholesaling scam in Tennessee, was convicted last week of 15 counts of mail fraud and one…
An influential senator said Teva is blocking her efforts to learn more about the company's opioid antidiversion programs.
Clinical care experts and patient advocacy organizations call attention to why better patient understanding shapes the best integrated approach to orphan drug…
As opioid scrutiny intensifies around the country, Mallinckrodt has received another subpoena seeking info about its sales of the powerful painkillers.
The day of judgment is near for Martin Shkreli, who has told a court he is misunderstood and deserves leniency.
Hundreds of cities and counties have sued to hold opioid makers accountable for the addiction epidemic. Now the feds are getting involved.
The court overseeing testosterone lawsuits has stayed all proceedings relating to Endo and GSK so the companies can work to settle their cases.
After a Friday ruling, Allergan's eye drug Restasis has to face the very patent challenge the company sought to prevent.
Pfizer could be on the hook for £502 million in National Health Service spending on Lyrica if a patent appeal fails, according to a new study.
The Novartis bribery scandal in Greece is entering a new phase with a governmental probe into 10 accused politicians.
Two politicians who allegedly played a role in the Greek Novartis scandal have filed criminal lawsuits against protected witnesses, according to the Associated…